{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:57:22Z","timestamp":1792083442546,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1053\/j.ajkd.2010.10.052","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T04:11:44Z","timestamp":1295151104000},"page":"498-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel Therapeutic Approaches to Lupus Glomerulonephritis: Translating Animal Models to Clinical Practice"],"prefix":"10.1053","volume":"57","author":[{"given":"Harini","family":"Bagavant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Kalantarinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Scindia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2010.10.052_bib1","series-title":"Immunologic Renal Diseases","first-page":"1057","article-title":"Systemic lupus erythematosus","author":"Cameron","year":"2001"},{"issue":"16","key":"10.1053\/j.ajkd.2010.10.052_bib2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenylate mofetil in patients with diffuse proliferative lupus nephritis","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2010.10.052_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis","volume":"350","author":"Contreras","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib4","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.174.4.1775","article-title":"B Cell selection and susceptibility to autoimmunity","volume":"174","author":"Grimaldi","year":"2005","journal-title":"J Immunol"},{"issue":"7","key":"10.1053\/j.ajkd.2010.10.052_bib5","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.171.7.3325","article-title":"T Cell rewiring in differentiation and disease","volume":"171","author":"Krishnan","year":"2003","journal-title":"J Immunol"},{"issue":"8","key":"10.1053\/j.ajkd.2010.10.052_bib6","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.4049\/jimmunol.174.8.5100","article-title":"Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation","volume":"174","author":"Zielinski","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"10.1053\/j.ajkd.2010.10.052_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1053\/j.ajkd.2010.10.052_bib8","first-page":"630","article-title":"Renal histologic findings in systemic lupus erythematosus","volume":"44","author":"Pollack","year":"1969","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol Med"},{"issue":"10","key":"10.1053\/j.ajkd.2010.10.052_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1084\/jem.20061446","article-title":"Persistent expression of autoantibodies in SLE patients in remission","volume":"203","author":"Yurasov","year":"2006","journal-title":"J Exp Med"},{"issue":"10","key":"10.1053\/j.ajkd.2010.10.052_bib11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J Exp Med"},{"issue":"1","key":"10.1053\/j.ajkd.2010.10.052_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncprheum0042","article-title":"B-Cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus","volume":"2","author":"Eisenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"suppl 10","key":"10.1053\/j.ajkd.2010.10.052_bib13","first-page":"271","article-title":"Efficacy and safety of rituximab in subjects with active proliferative lupus nephritis (Ln): results from the randomized, double-blind phase III LUNAR Study","volume":"60","author":"Furie","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1053\/j.ajkd.2010.10.052_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrneph.2009.64","article-title":"Glomerular disease: lupus nephritis trials end in disappointment","volume":"5","author":"Harman","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.10.052_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.ajkd.2010.10.052_bib16","doi-asserted-by":"crossref","first-page":"e8418","DOI":"10.1371\/journal.pone.0008418","article-title":"Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice","volume":"5","author":"Kawabata","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ajkd.2010.10.052_bib17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.27368","article-title":"Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice","volume":"62","author":"Ramanujam","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1053\/j.ajkd.2010.10.052_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrrheum.2009.79","article-title":"Systemic lupus erythematosus clinical trials-an interim analysis","volume":"5","author":"Dall'Era","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nrrheum.2010.20","article-title":"Connective tissue diseases: belimumab for systemic lupus erythematosus: breaking through?","volume":"6","author":"Dall'Era","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.20031519","article-title":"Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis","volume":"199","author":"Waters","year":"2004","journal-title":"J Exp Med"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00281-006-0030-7","article-title":"Genetics of SLE in mice","volume":"28","author":"Kono","year":"2006","journal-title":"Springer Semin Immunopathol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/clim.2001.5079","article-title":"NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci","volume":"100","author":"Waters","year":"2001","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib23","first-page":"419","article-title":"Differences in expression of lupus nephritis in New Zealand mixed H-2z-homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice","volume":"68","author":"Rudofsky","year":"1993","journal-title":"Lab Invest"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/1074-7613(94)90100-7","article-title":"Polygenic control of susceptibility to murine systemic lupus erythematosus","volume":"1","author":"Morel","year":"1994","journal-title":"Immunity"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1172\/JCI1817","article-title":"Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL\/6-Faslpr mice","volume":"101","author":"Vidal","year":"1998","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1385\/IR:24:2:211","article-title":"Of mice and men: the relevance of the mouse to the study of human SLE","volume":"24","author":"Birmingham","year":"2001","journal-title":"Immunol Res"},{"issue":"6","key":"10.1053\/j.ajkd.2010.10.052_bib27","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/ki.1992.242","article-title":"Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites","volume":"41","author":"Vlahakos","year":"1992","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clim.2007.05.007","article-title":"Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis","volume":"124","author":"Fu","year":"2007","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.ki.5000086","article-title":"Simvastatin protection against acute immune-mediated glomerulonephritis in mice","volume":"69","author":"Christensen","year":"2006","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2010.10.052_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1681\/ASN.V1271369","article-title":"Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis","volume":"12","author":"Lema","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.10.052_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1990.14","article-title":"Lupus nephritis: correlation of interstitial cells with glomerular function","volume":"37","author":"Alexopoulos","year":"1990","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1992.360","article-title":"Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis","volume":"42","author":"Diaz Gallo","year":"1992","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2010.10.052_bib33","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.4049\/jimmunol.177.11.8258","article-title":"Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes","volume":"177","author":"Bagavant","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"10.1053\/j.ajkd.2010.10.052_bib34","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.4049\/jimmunol.149.9.3083","article-title":"Development of murine lupus in CD4-depleted NZB\/NZW mice","volume":"149","author":"Connolly","year":"1992","journal-title":"J Immunol"},{"issue":"10","key":"10.1053\/j.ajkd.2010.10.052_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ki.2008.396","article-title":"Increased survival and reduced renal injury in MRL\/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist","volume":"4","author":"Wenderfer","year":"2008","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2010.10.052_bib36","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.4049\/jimmunol.166.5.2913","article-title":"Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide","volume":"166","author":"Daikh","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.10.052_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.171.1.489","article-title":"Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB\/W F1 mice by a mechanism downstream of renal immune complex deposition","volume":"171","author":"Schiffer","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.175.2.944","article-title":"Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis","volume":"175","author":"Bagavant","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1053\/j.ajkd.2010.10.052_bib39","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1681\/ASN.2006070733","article-title":"Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat","volume":"18","author":"Smith","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2010.10.052_bib40","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.172.8.5047","article-title":"Strain distribution pattern of susceptibility to immune-mediated nephritis","volume":"172","author":"Xie","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1172\/JCI36728","article-title":"Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans","volume":"119","author":"Liu","year":"2009","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2010.10.052_bib42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s11095-006-9213-0","article-title":"Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis","volume":"24","author":"Morimoto","year":"2007","journal-title":"Pharm Res"},{"issue":"21","key":"10.1053\/j.ajkd.2010.10.052_bib43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/bies.950171213","article-title":"Surrogate cells or Trojan horses: the discovery of liposomes","volume":"17","author":"Bangham","year":"1995","journal-title":"Bioessays"},{"key":"10.1053\/j.ajkd.2010.10.052_bib44","series-title":"Brenner & Rector's The Kidney","first-page":"3","article-title":"Anatomy of the kidney","author":"Madsen","year":"2004"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib45","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1046\/j.1523-1755.2003.00865.x","article-title":"Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis","volume":"63","author":"Carl","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2010.10.052_bib46","first-page":"629","article-title":"Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis","volume":"13","author":"Tomita","year":"2004","journal-title":"Int J Mol Med"},{"issue":"11","key":"10.1053\/j.ajkd.2010.10.052_bib47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.gt.3302236","article-title":"Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo","volume":"11","author":"Ahn","year":"2004","journal-title":"Gene Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1681\/ASN.2009030295","article-title":"siRNA-based therapy ameliorates glomerulonephritis","volume":"21","author":"Shimizu","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2010.10.052_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1357-4310(99)01482-3","article-title":"Gene therapy using HVJ liposomes: the best of both worlds","volume":"5","author":"Kaneda","year":"1999","journal-title":"Mol Med Today"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1152\/ajprenal.00391.2007","article-title":"Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded Ab Esel liposomes","volume":"294","author":"Asgeirsd\u00f3ttir","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.10.052_bib51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3346\/jkms.2004.19.3.374","article-title":"Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin induced diabetic rat kidney","volume":"19","author":"Jeong","year":"2004","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jcb.21440","article-title":"Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo","volume":"103","author":"Kang","year":"2008","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1053\/j.ajkd.2010.10.052_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-291X(05)80784-3","article-title":"Direct in vivo gene introduction into rat kidney","volume":"186","author":"Tomita","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1053\/j.ajkd.2010.10.052_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jgm.300","article-title":"Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes","volume":"4","author":"Tomita","year":"2002","journal-title":"J Gene Med"},{"issue":"14","key":"10.1053\/j.ajkd.2010.10.052_bib55","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.addr.2010.08.011","article-title":"Mesangial pathology in glomerular disease: targets for therapeutic intervention","volume":"62","author":"Scindia","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1053\/j.ajkd.2010.10.052_bib56","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1681\/ASN.2005050485","article-title":"Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney","volume":"16","author":"Tuffin","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2010.10.052_bib57","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/art.24026","article-title":"Anti\u2013\u03b18 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus","volume":"58","author":"Scindia","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1053\/j.ajkd.2010.10.052_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1242\/jcs.108.2.537","article-title":"Sequence and tissue distribution of the human integrin alpha subunit: beta1-associated alpha subunit expressed in smooth muscle cells","volume":"108","author":"Schnapp","year":"1995","journal-title":"J Cell Sci"},{"key":"10.1053\/j.ajkd.2010.10.052_bib59","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.184.Supp.93.40","article-title":"Role of T cell mediated inflammation in lupus-like glomerulonephritis (GN)","volume":"184","author":"Bagavant","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2010.10.052_bib60","first-page":"1172","article-title":"Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery","volume":"8","author":"Park","year":"2002","journal-title":"Clin Cancer Res"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610016665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610016665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:55:40Z","timestamp":1759456540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638610016665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0272638610016665"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.10.052","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Therapeutic Approaches to Lupus Glomerulonephritis: Translating Animal Models to Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}